Production and immunogenic efficacy of botulinum tetravalent (A, B, E, F) toxoid

Vaccine

Volumn 20, Issue 19-20, 2002, Pages 2556-2561

  Torii, Yasushi ^a,b   Tokumaru, Yoichi ^a   Kawaguchi, Seijirou ^a   Izumi, Nanae ^a   Maruyama, Seika ^a   Mukamoto, Masafumi ^c   Kozaki, Shunji ^c   Takahashi, Motohide ^d  

^a Chiba Serum Institute   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c Osaka Prefecture University   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Clostridium botulinum; ELISA; Mouse bioassay

Indexed keywords

BOTULINUM TOXIN; NEUTRALIZING ANTIBODY; BACTERIUM ANTIBODY;

ACTIVE IMMUNIZATION; ADULT; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; GUINEA PIG; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; TITRIMETRY; ANIMAL; BIOSYNTHESIS; BLOOD; BOTULISM; IMMUNOLOGY; SERODIAGNOSIS;

ADULT; ANIMAL; ANTIBODIES, BACTERIAL; BOTULINUM TOXINS; BOTULISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; GUINEA PIGS; HUMAN; MICE; NEUTRALIZATION TESTS; SUPPORT, NON-U.S. GOV'T; ANIMALS; HUMANS;

EID: 0037035869     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00157-3     Document Type: Article

References (16)

1. The origin, structure, and pharmacological activity of botulinum toxin
2. Botulism in the United States, 1899-1996
3. Clostridium botulinum toxins
4. Immunologic response of man to purified pentavalent ABCDE botulinum toxoid
5. Evalution of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid
6. Human immune response to botulinum pentavalent (ABCDE) toxoid determined by neutralization test and by an enzyme-linked immunosorbent assay
7. Antigenicity of Clostridium botulinum type E formol toxoid
8. Botulinum toxin in movement disorders
9. Development of vaccines for prevention of botulism
10. The immunogenicity in humans of a botulinum type F vaccine
11. Antibodies against botulinum neurotoxin
12. Immunological detection of Clostlidium botulinum toxin type A in therapeutic preparations
13. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes with dual label antibody